Primary Outcomes of a Phase II Randomized Trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE)

International Journal of Radiation Oncology*Biology*Physics(2019)

Cited 66|Views82
No score
Abstract
Mounting evidence supports complete metastatic ablation for oligometastatic cancer but the relevance of this approach to oligometastatic prostate cancer (OMPC) remain an area of active study. Importantly, biomarkers to determine patients who benefit most from complete ablation are unknown. We hypothesize that stereotactic ablative radiation (SABR) will improve oncologic outcomes in men with OMPC.
More
Translated text
Key words
oligometastatic prostate,prostate cancer,oriole,radiation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined